Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner

REFERENCES

• Osburn WO, Kensler TW. 2008. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659:31–39.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Yamamoto M. 2006. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46:113–140.
   PubMedGoogle Scholar
• Zhang DD. 2006. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38:769–789.
   PubMed Web of Science ®Google Scholar
• Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT. 2010. Cancer chemoprevention mechanisms mediated through the keap1-nrf2 pathway. Antioxid. Redox Signal. 13:1713–1748.
   PubMed Web of Science ®Google Scholar
• Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD. 2008. Dual roles of Nrf2 in cancer. Pharmacol. Res. 58:262–270.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, Igarashi K, Yamamoto M. 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24:7130–7139.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. 2004. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24:10941–10953.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. 2003. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23:8137–8151.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P. 2002. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U. S. A. 99:11908–11913.
   PubMed Web of Science ®Google Scholar
• McMahon M, Lamont DJ, Beattie KA, Hayes JD. 2010. Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. U. S. A. 107:18838–18843.
   PubMed Web of Science ®Google Scholar
• Baird L, Dinkova-Kostova AT. 2011. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 85:241–272.
   PubMed Web of Science ®Google Scholar
• Wondrak GT, Villeneuve NF, Lamore SD, Bause AS, Jiang T, Zhang DD. 2010. The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells. Molecules 15:3338–3355.
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98:3410–3415.
   PubMed Web of Science ®Google Scholar
• Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV, Biswal S. 2006. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3:e420. doi:10.1371/journal.pmed.0030420.
   PubMed Web of Science ®Google Scholar
• Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, Yamamoto M. 2006. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21:689–700.
   PubMed Web of Science ®Google Scholar
• Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, Hirohashi S. 2008. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135:1358–1368.
   PubMed Web of Science ®Google Scholar
• Nioi P, Nguyen T. 2007. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem. Biophys. Res. Commun. 362:816–821.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W, Zhang DD. 2010. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 70:5486–5496.
   PubMedGoogle Scholar
• Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, Hirohashi S. 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68:1303–1309.
   PubMed Web of Science ®Google Scholar
• Muscarella LA, Parrella P, D'Alessandro V, la Torre A, Barbano R, Fontana A, Tancredi A, Guarnieri V, Balsamo T, Coco M, Copetti M, Pellegrini F, De Bonis P, Bisceglia M, Scaramuzzi G, Maiello E, Valori VM, Merla G, Vendemiale G, Fazio VM. 2011. Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics 6:710–719.
   PubMed Web of Science ®Google Scholar
• Slocum SL, Kensler TW. 2011. Nrf2: control of sensitivity to carcinogens. Arch. Toxicol. 85:273–284.
   PubMed Web of Science ®Google Scholar
• Shim GS, Manandhar S, Shin DH, Kim TH, Kwak MK. 2009. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic. Biol. Med. 47:1619–1631.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, Zhang DD. 2008. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243.
   PubMed Web of Science ®Google Scholar
• Hu L, Miao W, Loignon M, Kandouz M, Batist G. 2010. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies. Cancer Chemother. Pharmacol. 66:467–474.
   PubMed Web of Science ®Google Scholar
• Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, Biswal S. 2008. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 68:7975–7984.
   PubMed Web of Science ®Google Scholar
• Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD. 2011. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc. Natl. Acad. Sci. U. S. A. 108:1433–1438.
   PubMed Web of Science ®Google Scholar
• Platanias LC. 2009. Biological responses to arsenic compounds. J. Biol. Chem. 284:18583–18587.
   PubMed Web of Science ®Google Scholar
• Flora SJ. 2011. Arsenic-induced oxidative stress and its reversibility. Free Radic. Biol. Med. 51:257–281.
   PubMed Web of Science ®Google Scholar
• Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. 2011. Arsenic exposure and toxicology: a historical perspective. Toxicol. Sci. 123:305–332.
   PubMed Web of Science ®Google Scholar
• Lau A, Whitman SA, Jaramillo MC, Zhang DD. 2013. Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway. J. Biochem. Mol. Toxicol. 27:99–105.
   PubMedGoogle Scholar
• Wang XJ, Sun Z, Chen W, Li Y, Villeneuve NF, Zhang DD. 2008. Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol. Appl. Pharmacol. 230:383–389.
   PubMed Web of Science ®Google Scholar
• Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP. 2003. Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp. Cell Res. 290:234–245.
   PubMed Web of Science ®Google Scholar
• Endo H, Sugioka Y, Nakagi Y, Saijo Y, Yoshida T. 2008. A novel role of the NRF2 transcription factor in the regulation of arsenite-mediated keratin 16 gene expression in human keratinocytes. Environ. Health Perspect. 116:873–879.
   PubMed Web of Science ®Google Scholar
• Aono J, Yanagawa T, Itoh K, Li B, Yoshida H, Kumagai Y, Yamamoto M, Ishii T. 2003. Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem. Biophys. Res. Commun. 305:271–277.
   PubMed Web of Science ®Google Scholar
• Meng D, Wang X, Chang Q, Hitron A, Zhang Z, Xu M, Chen G, Luo J, Jiang B, Fang J, Shi X. 2010. Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol. Appl. Pharmacol. 244:291–299.
   PubMedGoogle Scholar
• Rachakonda G, Xiong Y, Sekhar KR, Stamer SL, Liebler DC, Freeman ML. 2008. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 21:705–710.
   PubMed Web of Science ®Google Scholar
• Chai CY, Huang YC, Hung WC, Kang WY, Chen WT. 2007. Arsenic salts induced autophagic cell death and hypermethylation of DAPK promoter in SV-40 immortalized human uroepithelial cells. Toxicol. Lett. 173:48–56.
   PubMed Web of Science ®Google Scholar
• Bolt AM, Douglas RM, Klimecki WT. 2010. Arsenite exposure in human lymphoblastoid cell lines induces autophagy and coordinated induction of lysosomal genes. Toxicol. Lett. 199:153–159.
   PubMed Web of Science ®Google Scholar
• Bolt AM, Byrd RM, Klimecki WT. 2010. Autophagy is the predominant process induced by arsenite in human lymphoblastoid cell lines. Toxicol. Appl. Pharmacol. 244:366–373.
   PubMedGoogle Scholar
• Ichimura Y, Kominami E, Tanaka K, Komatsu M. 2008. Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy 4:1063–1066.
   PubMed Web of Science ®Google Scholar
• Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131–24145.
   PubMed Web of Science ®Google Scholar
• Itakura E, Mizushima N. 2011. p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J. Cell Biol. 192:17–27.
   PubMed Web of Science ®Google Scholar
• Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, Sun Z, White E, Zhang DD. 2010. A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30:3275–3285.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12:213–223.
   PubMed Web of Science ®Google Scholar
• Riley BE, Kaiser SE, Shaler TA, Ng AC, Hara T, Hipp MS, Lage K, Xavier RJ, Ryu KY, Taguchi K, Yamamoto M, Tanaka K, Mizushima N, Komatsu M, Kopito RR. 2010. Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection. J. Cell Biol. 191:537–552.
   PubMed Web of Science ®Google Scholar
• Copple IM, Lister A, Obeng AD, Kitteringham NR, Jenkins RE, Layfield R, Foster BJ, Goldring CE, Park BK. 2010. Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1-Nrf2 cell defense pathway. J. Biol. Chem. 285:16782–16788.
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T. 2010. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285:22576–22591.
   PubMed Web of Science ®Google Scholar
• Snow ET, Sykora P, Durham TR, Klein CB. 2005. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol. 207:557–564.
   PubMedGoogle Scholar
• Riley BE, Kaiser SE, Kopito RR. 2011. Autophagy inhibition engages Nrf2-p62 Ub-associated signaling. Autophagy 7:338–340.
   PubMed Web of Science ®Google Scholar
• He X, Chen MG, Lin GX, Ma Q. 2006. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 × Keap1 × Cul3 complex and recruiting Nrf2 × Maf to the antioxidant response element enhancer. J. Biol. Chem. 281:23620–23631.
   PubMed Web of Science ®Google Scholar
• Huerta-Olvera SG, Macias-Barragan J, Ramos-Marquez ME, Armendariz-Borunda J, Diaz-Barriga F, Siller-Lopez F. 2010. Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells. Environ. Toxicol. Pharmacol. 29:144–149.
   PubMed Web of Science ®Google Scholar
• Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, Mizushima N. 2011. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25:795–800.
   PubMed Web of Science ®Google Scholar
• Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, Lee MS, Tanaka K, Komatsu M. 2011. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J. Cell Biol. 193:275–284.
   PubMed Web of Science ®Google Scholar
• Inoue D, Kubo H, Taguchi K, Suzuki T, Komatsu M, Motohashi H, Yamamoto M. 2011. Inducible disruption of autophagy in the lung causes airway hyper-responsiveness. Biochem. Biophys. Res. Commun. 405:13–18.
   PubMedGoogle Scholar
• Wang XJ, Sun Z, Chen W, Eblin KE, Gandolfi JA, Zhang DD. 2007. Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol. Appl. Pharmacol. 225:206–213.
   PubMed Web of Science ®Google Scholar
• Jiang T, Huang Z, Chan JY, Zhang DD. 2009. Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol. Appl. Pharmacol. 240:8–14.
   PubMed Web of Science ®Google Scholar
• Du Y, Villeneuve NF, Wang XJ, Sun Z, Chen W, Li J, Lou H, Wong PK, Zhang DD. 2008. Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response. Environ. Health Perspect. 116:1154–1161.
   PubMed Web of Science ®Google Scholar
• Shinkai Y, Sumi D, Fukami I, Ishii T, Kumagai Y. 2006. Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes. FEBS Lett. 580:1771–1774.
   PubMed Web of Science ®Google Scholar